These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29442454)

  • 1. Higher concentrations of osteoprotegerin in type 1 diabetic patients are related to retinopathy: Results from the Poznań Prospective Study.
    Grzelka A; Naskręt D; Araszkiewicz A; Uruska A; Wegner M; Zozulińska-Ziółkiewicz D
    Adv Clin Exp Med; 2017 Dec; 26(9):1343-1349. PubMed ID: 29442454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
    Grauslund J; Rasmussen LM; Green A; Sjølie AK
    Scand J Clin Lab Invest; 2010 Apr; 70(3):188-93. PubMed ID: 20205614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum osteoprotegerin levels, endothelial function and carotid intima-media thickness in type 2 diabetic patients.
    Gunes M; Temizkan S; Apaydin T; Ilgin C; Haklar G; Gogas Yavuz D
    J Diabetes Complications; 2021 Dec; 35(12):108073. PubMed ID: 34635402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
    Nybo M; Poulsen MK; Grauslund J; Henriksen JE; Rasmussen LM
    Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.
    Giovannini S; Tinelli G; Biscetti F; Straface G; Angelini F; Pitocco D; Mucci L; Landolfi R; Flex A
    Cardiovasc Diabetol; 2017 Aug; 16(1):99. PubMed ID: 28789654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients.
    Xiang GD; Sun HL; Zhao LS
    Diabetes Res Clin Pract; 2007 May; 76(2):199-206. PubMed ID: 17023086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients.
    Rasmussen LM; Tarnow L; Hansen TK; Parving HH; Flyvbjerg A
    Eur J Endocrinol; 2006 Jan; 154(1):75-81. PubMed ID: 16381994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus.
    Chrysis D; Efthymiadou A; Mermigka A; Kritikou D; Spiliotis BE
    Pediatr Diabetes; 2017 Jun; 18(4):277-282. PubMed ID: 27028343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance.
    O'Sullivan EP; Ashley DT; Davenport C; Penugonda L; Kelleher G; Devlin N; Crowley R; O'Shea P; Agha A; Thompson CJ; O'Gorman DJ; Smith D
    Metabolism; 2013 Jan; 62(1):34-8. PubMed ID: 22841521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher risk of microvascular complications in smokers with type 1 diabetes despite intensive insulin therapy.
    Uruska A; Araszkiewicz A; Uruski P; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2014 Mar; 92():79-84. PubMed ID: 24423616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
    Elsamahy MH; Elhenawy YI; Nawar MM
    J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.
    Tavintharan S; Pek LT; Liu JJ; Ng XW; Yeoh LY; Su Chi L; Chee Fang S
    Diab Vasc Dis Res; 2014 Sep; 11(5):359-62. PubMed ID: 25005034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin as a marker of cardiovascular risk in children and adolescents with type 1 diabetes.
    Fekih O; Triki H; Triki S; Neffati F; Chouchane S; Guediche MN; Najjar MF
    Pediatr Diabetes; 2017 May; 18(3):230-236. PubMed ID: 27111559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
    Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
    Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin as a marker of atherosclerosis in type 1 and type 2 diabetic patients.
    Alkaç C; Alkaç B; Akbaş F; Aral H; Karagöz Y; Altunoğlu EG
    Turk J Med Sci; 2015; 45(6):1306-11. PubMed ID: 26775387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
    Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
    Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status.
    Galluzzi F; Stagi S; Salti R; Toni S; Piscitelli E; Simonini G; Falcini F; Chiarelli F
    Eur J Endocrinol; 2005 Dec; 153(6):879-85. PubMed ID: 16322394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.
    Wang ST; Xu JM; Wang M; Chen FL; Ding G
    Clin Nephrol; 2013 Mar; 79(3):192-8. PubMed ID: 23073066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes.
    Gordin D; Soro-Paavonen A; Thomas MC; Harjutsalo V; Saraheimo M; Bjerre M; Forsblom C; Flyvbjerg A; Groop PH;
    Diabetes Care; 2013 Jul; 36(7):1827-33. PubMed ID: 23801795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.